论文部分内容阅读
目的 The FLT3-ITD mutation is an independent risk factor for poor prognosis of acute myeloid leukemia(AML).Allogeneic hematopoietic stem cell transplantation(allo-HSCT)may improve the prognosis of AML with the FLT3-ITD mutation.